Literature DB >> 16093909

Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study.

Taku Obara1, Takayoshi Ohkubo, Jin Funahashi, Masahiro Kikuya, Kei Asayama, Hirohito Metoki, Takuya Oikawa, Junichiro Hashimoto, Kazuhito Totsune, Yutaka Imai.   

Abstract

OBJECTIVES: To evaluate the current status of blood pressure (BP) control as measured at home and in the office, as well as to clarify and compare the prevalence and characteristics of isolated uncontrolled hypertension as measured at home (home hypertension) and in the office (office hypertension).
DESIGN: A cross-sectional study.
SETTING: Primary care offices in Japan. PARTICIPANTS: A sample of 3400 patients with essential hypertension (mean age, 66 years; males, 45%) receiving antihypertensive treatment.
RESULTS: Overall, the mean home systolic BP (SBP)/diastolic BP (DBP) was 140/82 mmHg, and the mean office SBP/DBP was 143/81 mmHg. Of the 3400 subjects, 19% had controlled hypertension (home SBP/DBP < 135/85 mmHg and office SBP/DBP < 140/90 mmHg), 23% had isolated uncontrolled home hypertension (home SBP/DBP >/= 135/85 mmHg and office SBP/DBP < 140/90 mmHg), 15% had isolated uncontrolled office hypertension (home SBP/DBP < 135/85 mmHg and office SBP/DBP < 140/90 mmHg), and 43% had uncontrolled hypertension (home SBP/DBP >/= 135/85 mmHg and office SBP/DBP >/= 140/90 mmHg). Compared to controlled hypertension, factors associated with isolated uncontrolled home hypertension included obesity, relatively higher office SBP, habitual drinking, and the use of two or more prescribed antihypertensive drugs. Compared to uncontrolled hypertension, factors associated with isolated uncontrolled office hypertension included female gender, lower body mass index, and relatively lower office SBP.
CONCLUSIONS: The use of all four, three of four, or all three predictive factors might be useful for the clinician to suspect isolated uncontrolled home or office hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16093909     DOI: 10.1097/01.hjh.0000178334.33352.56

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  25 in total

Review 1.  Masked hypertension: a common but insidious presentation of hypertension.

Authors:  D W McKay; Martin G Myers; Peter Bolli; Arun Chockalingam
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

Review 2.  Ambulatory blood pressure monitoring in childhood and adult obesity.

Authors:  Iddo Z Ben-Dov; Michael Bursztyn
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

Review 3.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

Review 4.  Prevalence of white-coat and masked hypertension in national and international registries.

Authors:  Manuel Gorostidi; Ernest Vinyoles; José R Banegas; Alejandro de la Sierra
Journal:  Hypertens Res       Date:  2014-10-16       Impact factor: 3.872

5.  Diagnosis and Control of Hypertension in the Elderly Populations of Japan and the United States.

Authors:  Yasuhiko Saito; Shieva Davarian; Atsuhiko Takahashi; Edward Schneider; Eileen M Crimmins
Journal:  Int J Popul Stud       Date:  2015-12-31

6.  Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study.

Authors:  Daichi Shimbo; Jonathan D Newman; Joseph E Schwartz
Journal:  Am J Hypertens       Date:  2012-03-01       Impact factor: 2.689

7.  Frequency and related factors of masked hypertension at a worksite in Korea.

Authors:  Sang-Kyu Kim; Jun-Ho Bae; Dung-Young Nah; Dong-Wook Lee; Tae-Yoon Hwang; Kyeong-Soo Lee
Journal:  J Prev Med Public Health       Date:  2011-05

8.  Diagnosis of true uncontrolled hypertension using both home and ambulatory blood pressure monitoring.

Authors:  K Kario
Journal:  J Hum Hypertens       Date:  2013-08-08       Impact factor: 3.012

9.  Should we screen for masked hypertension in patient with vascular disease?

Authors:  Pascal Delsart; Philippe Marboeuf; Cedric Delhaye; Gilles Lemesle; Claire Mounier-Vehier
Journal:  Vasc Health Risk Manag       Date:  2010-05-25

10.  Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients.

Authors:  Eui-Seock Hwang; Kee-Joon Choi; Duk-Hyun Kang; Gi-Byoung Nam; Jae-Sik Jang; Young-Hoon Jeong; Chang-Hoon Lee; Ji-Young Lee; Hyun-Koo Park; Chong-Hun Park
Journal:  Korean J Intern Med       Date:  2007-12       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.